Primary Record
bekanamycin
- In stock
- 3,699 g
- Purity
- 99.8 %
- CAS
- 4696-76-8
Compound Identifiers & Properties
- CAS
- 4696-76-8
- PubChem CID
- 439318
- SMILES
- C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)N)N
- Canonical SMILES
- NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)[C@@H](O)[C@@H]1O
Names & Synonyms
- bekanamycin
- Kanamycin B
- Nebramycin V
- Bekanamycine
- Aminodeoxykanamycin
- Bekanamycinum
- Kanendomycin
- Becanamicina
- Bekanamicina
- nebramycin factor 5
- 4696-76-8
- becanamycin
- kanamycin
- Kantrex
- Klebcil
- Bekanamycin [INN]
- kananmycin B
- nebramycinfactor5
- Bekanamycin sulfate
- 2'-Amino-2'-deoxykanamycin
- Bekanamycin (INN)
- Nebramycin factor-5
- AMMELINE
- Spectrum_001112
- Bekanamycine [INN-French]
- Bekanamycinum [INN-Latin]
- Becanamicina [INN-Spanish]
- Kanamycin B; Bekanamycin
- NK 1006
- RefChem:561213
- Spectrum2_000640
- Spectrum3_000619
- Spectrum4_001831
- Spectrum5_000621
- 15JT14C3GI
- Tobramycin EP Impurity A
- UNII-15JT14C3GI
- KANAMYCIN B [MI]
- DTXSID8023185
- CHEMBL176
- DTXCID903185
- NK-1006
- MFCD01683541
- BEKANAMYCIN [WHO-DD]
- BSPBio_002158
- KBioGR_002528
- KBioSS_001592
- CHEBI:28098
- SCHEMBL158426
- SPBio_000640
- AC1L974E
- MEGxm0_000486
- orb1299205
- ACon0_001346
- C18H37N5O10
- EINECS 225-170-5
- GTPL12182
- KBio2_001592
- KBio2_004160
- KBio2_006728
- KBio3_001658
- J01GB13
- SKKLOUVUUNMCJE-FQSMHNGLSA-N
- HY-B1174
- BRN 0061646
- Tox21_113194
- BBF-01885
- BDBM50368267
- CID439318
- EBC-98151
- ZINC53132258
- AKOS030526149
- ACN-043771
- AK31430
- C18-H37-N5-O10
- CS-4772
- DB13673
- J8.763G
- Kanamycin B; Tobramycin EP Impurity A
- SDCCGMLS-0066707.P001
- NCGC00096063-01
- NCGC00178790-01
- SY365104
- CAS-4696-76-8
- SBI-0052603.P002
- TOBRAMYCIN IMPURITY A [EP IMPURITY]
- FT-0696935
- NS00011539
- 4-18-00-07631 (Beilstein Handbook Reference)
- C00825
- C11235
- D07497
- (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-(((1R,2S,3S,4R,6S)-4,6-diamino-3-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)tetrahydro-2H-pyran-3,4-diol
- AB00053732_02
- A924196
- Antibiotic derived from Streptomyces kanamyceticus
- F787610
- Q3637540
- BRD-K73425385-001-01-9
- BRD-K73425385-065-04-8
- (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2S,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol
- Antibiotic derived from Streptomyces kanamyceticus. Kanamycin B
- (1R,2S,3S,4R,6S)-4,6-diamino-3-(3-amino-3-deoxy-alpha-D-glucopyranosyloxy)-2-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside
- (1R,2S,3S,4R,6S)-4,6-diamino-3-[(3-amino-3-deoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside
- (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2S,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
- KDM
- O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->4)-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1->6))-2-deoxy-D-streptamine
- (1R,2S,3S,4R,6S)-4,6-DIAMINO-3-((3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL)OXY)-2-HYDROXYCYCLOHEXYL 2,6-DIAMINO-2,6-DIDEOXY-.ALPHA.-D-GLUCOPYRANOSIDE
- (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-((1R,2S,3S,4R,6S)-4,6-diamino-3-((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-2-hydroxycyclohexyl)oxyoxane-3,4-diol
- (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(1R,2S,3S,4R,6S)-4,6-diamino-3-{[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}oxane-3,4-diol
- .ALPHA.-D-GLUCOPYRANOSIDE, (1R,2S,3S,4R,6S)-4,6-DIAMINO-3-((3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL)OXY)-2-HYDROXYCYCLOHEXYL 2,6-DIAMINO-2,6-DIDEOXY-
- 225-170-5
- 6-O-(3-Amino-3-deoxy-alpha-D-glucopyranosyl)-4-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-2-deoxy-D-streptamine
- 9CS
- D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1.fwdarw.6)-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1.fwdarw.4)]-2-deoxy-
- D-Streptamine, O-3-amino-3-deoxy-a-D-glucopyranosyl-(1?6)-O-[2,6-diamino-2,6-dideoxy-a-D-glucopyranosyl-(1?4)]-2-deoxy-; Kanamycin B (7CI,8CI); O-3-Amino-3-deoxy-a-D-glucopyranosyl-(1?6)-O-[2,6-diamino-2,6-dideoxy-a-D-glucopyranosyl-(1?4)]-2-deoxy-D-streptamine; 2'-Amino-2'-deoxykanamycin; Aminodeoxykanamycin; Beckanamycin; Bekanamycin; KDM; Kanendomycin; NK 1006; Nebramycin V; Nebramycin factor 5
- D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-6))-2-deoxy-